We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Imaging Genetic Study of Schizophrenia and Family

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2014 by Yuqi Cheng, Kunming Medical University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01259232
First Posted: December 14, 2010
Last Update Posted: March 21, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Chinese Academy of Sciences
Information provided by (Responsible Party):
Yuqi Cheng, Kunming Medical University
  Purpose
To investigate the brain abnormalities and the association with gene in schizophrenia patients and their relatives.

Condition
Schizophrenia

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Yuqi Cheng, Kunming Medical University:

Primary Outcome Measures:
  • the association between gene and fMRI in schizophrenia patients [ Time Frame: 30 days after diagnosis ]

Estimated Enrollment: 100
Study Start Date: September 2011
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
schizophrenia patients,untreated
schizophrenia relatives
controls

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
schizophrenia patients and their relatives
Criteria

Inclusion Criteria:

  • Clinical diagnosis of schizophrenia(DSM-IV)
  • total score of PANSS>64

Exclusion Criteria:

  • other psychiatric disease,
  • organic disease
  • neurological disease
  • unstable physiological status
  • age>65
  • pregnant
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01259232


Contacts
Contact: Yuqi Cheng 8613888122013 yuqich@163.com
Contact: Xiufeng Xu xfxu2004@sina.com

Locations
China, Yunnan
Psychiatry department, The 1st Affiliated Hospital of Kunming Medical University Recruiting
Kunming, Yunnan, China, 650032
Contact: Xiufeng Xu       xfxu2004@sina.com   
Sponsors and Collaborators
Kunming Medical University
Chinese Academy of Sciences
Investigators
Study Director: Xiufeng Xu Psychiatry Department
  More Information

Responsible Party: Yuqi Cheng, Kunming Medical University
ClinicalTrials.gov Identifier: NCT01259232     History of Changes
Other Study ID Numbers: SCH001
KMC2010L4
First Submitted: December 10, 2010
First Posted: December 14, 2010
Last Update Posted: March 21, 2014
Last Verified: March 2014

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders